Clinical trial
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
NCT02312882 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- August 31, 2015
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alopecia areata, alopecia totalis, alopecia universalis